Price T Rowe Associates Inc X Biotech Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XBIT
# of Institutions
47Shares Held
4.67MCall Options Held
5.8KPut Options Held
4.6K-
Black Rock Inc. New York, NY1.13MShares$8.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$7.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA430KShares$3.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny362KShares$2.61 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL248KShares$1.79 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $219M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...